Fig. 6
From: Comprehensive analysis of UPK3B as a marker for prognosis and immunity in pancreatic adenocarcinoma
Validation of UPK3B in scRNA-seq. (A) UMAP dimensionality reduction plots for various cell types. (B) UPK3B expression in malignant cells. (C, D) KEGG and GO enrichment analysis results for marker genes in UPK3B-positive malignant cells. (E) GSEA results show that immune activation-related pathways are downregulated in UPK3B-positive malignant cells.
